VANCOUVER, BC / ACCESSWIRE / March 13, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce today that it has cancelled and will not utilize the acceleration provisions in regards to 11,024,612 warrants previously issued (the “Warrants”). If the average closing price of CVR Medical’s common [...]
VANCOUVER, BC / ACCESSWIRE / March 9, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has entered into a letter of intent with CVR Global Inc. (“CVR Global”) to acquire an additional 10% interest of the “Joint Venture Business” from CVR Global’s current [...]
VANCOUVER, BC / ACCESSWIRE / February 23, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,500,000 (the "Financing"). An aggregate of 7,142,858 units ("Units") were issued at a price of [...]
VANCOUVER, BC / ACCESSWIRE / February 13, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") previously announced its intention to complete a private placement financing for gross proceeds of up to $2,500,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share [...]
VANCOUVER, BC / ACCESSWIRE / February 9, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Benjamin Asuncion to its Board of Directors. From this position, Mr. Asuncion will serve in capital market advisory and valuation capacities as CVR Medical moves towards market launch. Benjamin Asuncion has over [...]
VANCOUVER, BC / ACCESSWIRE / February 7, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that, due to strong demand, the Company has increased the size of its previously announced private placement financing to 7.58 million units (the “Units”), at a price of $0.33 per [...]
VANCOUVER, BC / ACCESSWIRE / February 6, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $1,250,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share [...]
VANCOUVER, BC / ACCESSWIRE / February 6, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has retained the services of DuVal & Associates, P.A., a Minneapolis-based, regulatory law firm focused on counsel within the medical device and pharmaceutical industries. In addition to its strategic advisory role, DuVal & Associates [...]
VANCOUVER, BC / ACCESSWIRE / January 26, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has retained the services of Cozen O’Connor. The Philadelphia-based law firm will work with CVR to obtain and protect patents related to the technology being implemented in the “Carotid Stenotic Scan (CSS)” device. One [...]
VANCOUVER, BC / ACCESSWIRE / January 18, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") issues correction on the following statement regarding the conduction of clinical trials, previously posted on January 12, 2017: CVR Medical Corp. is pleased to announce that its “Carotid Stenotic Scan (CSS)” device has received [...]
